文献速递胃肠动力与功能性疾病消化内镜

食管总体症状严重程度作为患者报告结局评估反流症状的验证

Validation of Esophageal Global Symptom Severity as a Patient-Reported Outcome for Evaluation of Reflux Symptoms.
PubMed 文献 · Am J Gastroenterol · 2025-04-23

该研究汇总三大洲接受pH-阻抗监测的反流症状患者数据,评估视觉模拟量表(VAS)测量的食管总体症状严重程度(GSS)与经验证问卷、食管症状负荷及治疗结局的关系。结果显示GSS与GERDQ、GERD-HRQL、RSI、酸暴露时间及反流事件总数显著相关,在预测病理性酸暴露和确诊GERD方面不劣于经验证问卷,且治疗前后GSS变化与GERDQ变化及治疗满意度相关。

要点

  • GSS与GERDQ、GERD-HRQL、RSI、酸暴露时间及反流事件总数均显著相关(P<0.0001)。
  • GERDQ、GERD-HRQL、RSI异常及病理性酸暴露、确诊GERD者平均GSS更高(P<0.0001)。
  • GSS在预测病理性酸暴露、反流事件总数及确诊GERD方面不劣于经验证问卷。

核心结论

  • GSS与其他经验证的反流问卷相关,可区分反流症状患者的异常与正常反流负荷。
  • GSS变化反映抗反流治疗结局和满意度,是GERD治疗前后患者症状评估的有用补充。

研究设计与样本

  • 汇总已发表历史队列的合并数据分析,纳入因反流症状接受pH-阻抗监测的患者,来自北美、欧洲和亚洲3大洲。
  • 采用单变量(Spearman相关)、多变量(一般线性回归)和受试者工作特征分析,将GSS与GERDQ、GERD-HRQL、RSI及按Lyon共识2.0的pH-阻抗指标进行比较。

主要发现

  • GSS与GERDQ(R=0.455)、GERD-HRQL(R=0.440)、RSI(R=0.491)、酸暴露时间(R=0.158)及反流事件总数(R=0.161)显著相关,每项比较P<0.0001。
  • GERDQ异常、GERD-HRQL异常、RSI异常、病理性酸暴露及按Lyon共识确诊GERD者平均GSS更高,每项比较P<0.0001。
  • 受试者工作特征分析显示,GSS在预测病理性酸暴露、反流事件总数及确诊GERD方面不劣于GERDQ、GERD-HRQL和RSI。
  • 抗反流治疗后GSS改善百分比与GERDQ变化(R=0.536,P<0.0001)及治疗满意度(R=0.532,P=0.0002)显著相关。
  • 多变量线性回归分析中,GSS变化百分比仍是GERDQ变化(β=0.813,P<0.0001)和治疗满意度(β=1.90,P=0.0006)的独立预测因子。

临床怎么用

  • 原文结论认为GSS是GERD治疗前后患者症状评估的有用补充。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Visual Analog Scales (VAS) are simple, easy for patients to comprehend, and require limited translation. We evaluated the value of esophageal global symptom severity (GSS) measured using VAS in assessing initial reflux symptom burden as compared with other validated questionnaires, esophageal symptom burden, and outcome after reflux management. METHODS: We analyzed pooled data from published historical cohorts of patients undergoing pH-impedance testing for reflux symptoms from 3 continents (North America, Europe, Asia). Univariate (Spearman correlation), multivariable (general linear regression), and receiver operating characteristic analyses were performed to compare GSS with validated symptom instruments including gastroesophageal reflux disease questionnaire (GERDQ), GERD health-related quality of life (GERD-HRQL), Reflux Symptom Index (RSI), and metrics from pH-impedance monitoring per Lyon Consensus 2.0. RESULTS: One thousand two hundred ninety-six patients (mean age 52.0 years, 61.9% female) were included: 937, 197, and 162 from North America, Europe, and Asia, respectively. GSS significantly correlated with GERDQ (R = 0.455), GERD-HRQL (R = 0.440), RSI (R = 0.491), acid exposure time (AET) (R = 0.158), and total reflux episodes (R = 0.161) ( P < 0.0001 for each comparison). The mean GSS was higher with abnormal GERDQ, GERD-HRQL, RSI, pathologic AET, and conclusive GERD per Lyon Consensus ( P < 0.0001 each comparison). On receiver operating characteristic analyses, GSS was noninferior to GERDQ, GERD-HRQL, and RSI in predicting pathologic AET and total reflux episodes, and conclusive GERD. Percentage improvement in GSS after antireflux treatment significantly correlated with change in GERDQ (R = 0.536, P < 0.0001) and treatment satisfaction (R = 0.532 P = 0.0002). On multivariable linear regression analyses, percentage change in GSS remained an independent predictor of both change in GERDQ (β = 0.813, P < 0.0001) and satisfaction with antireflux therapy (β = 1.90, P = 0.0006). DISCUSSION: GSS correlates with other validated reflux questionnaires and discriminates abnormal from normal reflux burden in patients with reflux symptoms. GSS change also reflects reflux treatment outcome and satisfaction. GSS is a useful addition to patient symptom assessment before and after GERD treatment.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Chan WW, Schroeder M, Richardson A, et al. Validation of Esophageal Global Symptom Severity as a Patient-Reported Outcome for Evaluation of Reflux Symptoms. Am J Gastroenterol. 2025. PMID: 40267269. doi:10.14309/ajg.0000000000003499

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。